SCHEMBL2561665

SCHEMBL2561665

CNC(CSC)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11505165 1.00
SCHEMBL14227052 0.85 ITGB1 (0.42)
SCHEMBL15844914 0.85 ITGB1 (0.42)
SCHEMBL15844913 0.85 ITGB1 (0.42)
SCHEMBL13007991 0.84 ITGB1 (0.35)
SCHEMBL18403953 0.84 ITGB1 (0.35)
SCHEMBL16310690 0.81
SCHEMBL616501 0.81 KDM4E (0.34)
SCHEMBL1925530 0.81
SCHEMBL616502 0.81 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0001309-A1 Meat aroma precursor composition THE PROCTER &amp; GAMBLE COMPANY (US) 1979-04-04 EP claimed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
US-10933142-B2 Reversible covalent linkage of functional molecules UCL BUSINESS LTD (GB) 2021-03-02 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20170281785-A1 GLYCEROL LINKED PEGYLATED SUGARS AND GLYCOPEPTIDES NOVO NORDISK A/S (DK) 2017-10-05 US disclosed
US-9493499-B2 Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography NOVO NORDISK A/S (DK) 2016-11-15 US disclosed
US-20160158319-A1 REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF) NOVO NORDISK A/S (DK) 2016-06-09 US disclosed
US-9050304-B2 Methods of treatment using glycopegylated G-CSF RATIOPHARM GMBH (DE) 2015-06-09 US disclosed
US-8911967-B2 One pot desialylation and glycopegylation of therapeutic peptides NOVO NORDISK A/S (DK) 2014-12-16 US disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
US-20130137157-A1 GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA NOVO NORDISK A/S (DK) 2013-05-30 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
US-20100249027-A1 CRF CONJUGATES WITH EXTENDED HALF-LIVES HENRY WILLIAM 2010-09-30 US disclosed
US-7629744-B2 In-gel tagging and in-gel digestion for phosphoproteins analysis and phosphorylation site identification KOREA BASIC SCIENCE INSTITUTE (KR) 2009-12-08 US disclosed
US-20090155186-A1 Compositions and methods for treating inflammatory conditions SIGNUM BIOSCENCES, INC. (NJ) 2009-06-18 US disclosed